Valuation: Enovis Corporation

Market Cap 1.3B 1.13B 1.04B 969M 1.84B 123B 1.87B 12.51B 4.85B 60.48B 4.86B 4.76B 208B P/E 2026 *
185x
P/E 2027 * 23.3x
Enterprise Value 2.49B 2.18B 2B 1.87B 3.54B 237B 3.6B 24.08B 9.33B 116B 9.36B 9.16B 401B EV / Sales 2026 *
1.06x
EV / Sales 2027 * 0.96x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+12.28%
1 week+2.23%
Current month+8.70%
1 month+2.55%
3 months-0.62%
6 months-15.13%
Current year-15.54%
1 week 19.14
Extreme 19.14
22.71
1 month 19.14
Extreme 19.14
24.58
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
36.82
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Administrative Officer - 2026-01-04
Director TitleAgeSince
Director/Board Member 59 2022-04-03
Director/Board Member 55 2008-05-12
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Chief Administrative Officer

1,000 0.0017%
06-10Buy

Chief Administrative Officer

1,200 0.0021%
06-10Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+12.28%+2.23%-32.76%-64.91% 1.15B
+4.20%+3.30%-16.66%+7.03% 120B
+2.92%-2.26%+0.67%-11.16% 12.33B
+7.83%+4.05%+43.14%+108.31% 8.08B
-0.64%+1.67%-48.31%-71.81% 4B
+1.85%+2.81%+18.98%+40.15% 2.57B
-1.23%+3.87%-12.07%-14.48% 1.86B
-0.41%+1.29%-5.26%-25.04% 1.62B
-3.31%-6.90%+221.83%+153.84% 1.58B
Average +2.61%+2.86%+18.84%+13.55% 17.04B
Weighted average by Cap. +3.99%+0.16%-9.83%+9.77%

Financials

2026 *2027 *
Net sales 2.34B 2.05B 1.88B 1.75B 3.33B 223B 3.38B 22.65B 8.78B 109B 8.8B 8.61B 377B 2.47B 2.16B 1.98B 1.85B 3.5B 235B 3.56B 23.83B 9.24B 115B 9.26B 9.06B 397B
Net income 2.96M 2.59M 2.38M 2.21M 4.2M 282M 4.27M 28.6M 11.08M 138M 11.11M 10.87M 476M 54.22M 47.38M 43.51M 40.57M 76.91M 5.16B 78.21M 524M 203M 2.53B 204M 199M 8.72B
Net Debt 1.2B 1.05B 961M 896M 1.7B 114B 1.73B 11.57B 4.48B 55.91B 4.5B 4.4B 193B 1.07B 931M 855M 798M 1.51B 101B 1.54B 10.3B 3.99B 49.77B 4B 3.92B 172B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-07-02 US$22.50 +12.28% 1,302,482
26-07-01 US$20.04 -3.19% 1,502,881
26-06-30 US$20.70 -5.99% 2,373,298
26-06-29 US$22.02 -3.04% 1,403,504
26-06-26 US$22.71 +3.18% 1,929,548
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
22.50USD
Average target price
42.30USD
Spread / Average Target
+88.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock